At its heart, Landmark Bio is a cell and gene therapy manufacturing company, focused on the development of innovative technologies, products and services to bridge the gap from bench to patient.
Whether you’re an academic researcher vetting therapeutic targets, a physician scientist preparing for an IND filing, or a biopharma leader advancing your pipeline product to the clinic, the right development partner can help remove obstacles, maximize efficiency, and meet milestones at an accelerated pace.
For more information please contact info@landmarkbio.com
Company Details
- Employees
- 76
- Address
- 300 N Beacon St, Watertown,massachusetts 02472,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.landmarkbio.com
- HQ
- Watertown, Massachusetts
Landmark Bio Questions
Landmark Bio's website is http://www.landmarkbio.com
Landmark Bio's LinkedIn profile is https://www.linkedin.com/company/landmarkbio
Landmark Bio has
76 employees.
View email and phone details for 76
employees at Landmark Bio.
Landmark Bio's industry is
Biotechnology Research
Landmark Bio's top competitors are
Sarepta Therapeutics,
Alnylam Pharmaceuticals,
Beam Therapeutics,
Corner Therapeutics,
Vertex Pharmaceuticals,
Tessera Therapeutics,
Kojin Therapeutics,
Kisbee Therapeutics,
Artis Biosolutions,
Elevatebio.
Landmark Bio's categories are Biotechnology Research
